Vigil Neuroscience, Inc. (VIGL)

Vigil Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.21	39.02	51.99	186.61	91.42	24.15
Short-Term Investments	25.77	58.78	65.95	-	-	-
Cash & Short-Term Investments	66.99	97.8	117.94	186.61	91.42	24.15
Cash Growth	-22.72%	-17.08%	-36.80%	104.12%	278.54%	-
Other Receivables	0.56	0.6	1.49	0.02	-	-
Receivables	0.56	0.6	1.49	0.02	-	-
Prepaid Expenses	1.75	1.34	1.69	6.8	5.7	1.08
Other Current Assets	1	0.85	0.8	4.38	0.36	0.07
Total Current Assets	70.29	100.58	121.91	197.81	97.48	25.3
Property, Plant & Equipment	15.46	16.09	17.94	1.4	1.27	-
Long-Term Deferred Charges	-	-	-	-	2.76	-
Other Long-Term Assets	0.95	1.02	1.01	1.19	0.93	-
Total Assets	86.7	117.69	140.86	200.39	102.44	25.3

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	1.55	1.97	1.95	1.94	3.98	1.11
Accrued Expenses	8	10.85	8.49	7.39	4.37	0.87
Current Portion of Leases	1.11	1.04	0.91	0.18	0.87	-
Current Unearned Revenue	20.01	20.01	-	-	-	-
Other Current Liabilities	3.44	0.29	0.32	1.8	0.66	0.02
Total Current Liabilities	34.11	34.15	11.66	11.31	9.88	2
Long-Term Debt	-	-	-	-	-	0.3
Long-Term Leases	11.33	11.91	12.95	-	0.06	-
Other Long-Term Liabilities	-	-	-	-	-	4.25
Total Liabilities	45.44	46.06	24.61	11.31	9.95	6.55

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.01	0	0	0	-	-
Additional Paid-In Capital	397.35	378.63	339.03	329.21	2.39	0.26
Retained Earnings	-356.1	-307.03	-222.77	-140.13	-71.83	-28.55
Comprehensive Income & Other	0	0.03	-0.01	-	-	-
Total Common Equity	41.26	71.64	116.25	189.08	-69.44	-28.28
Shareholders' Equity	41.26	71.64	116.25	189.08	92.5	18.75
Total Liabilities & Equity	86.7	117.69	140.86	200.39	102.44	25.3

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	12.44	12.95	13.85	0.18	0.94	0.3
Net Cash (Debt)	54.55	84.85	104.09	186.43	90.48	23.85
Net Cash Growth	-25.55%	-18.48%	-44.17%	106.04%	279.42%	-
Net Cash Per Share	1.24	2.09	2.69	5.88	59.07	17.67
Filing Date Shares Outstanding	47.7	46.67	36.88	35.64	28.27	1.75
Total Common Shares Outstanding	47.69	40.89	35.88	35.62	1.72	1.75
Working Capital	36.18	66.44	110.25	186.49	87.6	23.3
Book Value Per Share	0.87	1.75	3.24	5.31	-40.26	-16.17
Tangible Book Value	41.26	71.64	116.25	189.08	-69.44	-28.28
Tangible Book Value Per Share	0.87	1.75	3.24	5.31	-40.26	-16.17
Machinery	-	1.89	1.89	0.3	0.2	-
Construction In Progress	-	-	-	0.94	0.1	-
Leasehold Improvements	-	0.23	0.23	-	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error